February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Finance Committee Advances Social Security, USTR, HHS Nominations
- Crapo Statement at Hearing on the Rising Cost of Health Care
- Crapo Statement at Executive Session to Consider Social Security, USTR, HHS Nominations
- Crapo Announces Finance Committee Staff Updates
- Crapo Announces Executive Session, Hearing on Rising Health Care Costs